Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,126 | 413 | 56.8% |
| Consulting Fee | $3,850 | 3 | 30.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,500 | 1 | 12.0% |
| Travel and Lodging | $56.28 | 1 | 0.4% |
| Education | $4.76 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axsome Therapeutics, Inc. | $5,830 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,886 | 128 | $0 (2024) |
| Lundbeck LLC | $688.29 | 45 | $0 (2024) |
| ABBVIE INC. | $482.39 | 24 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $424.13 | 23 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $381.91 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $376.63 | 25 | $0 (2024) |
| Allergan, Inc. | $355.51 | 33 | $0 (2020) |
| ITI, Inc. | $303.12 | 10 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $213.08 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,355 | 52 | Axsome Therapeutics, Inc. ($5,468) |
| 2023 | $1,290 | 67 | Otsuka America Pharmaceutical, Inc. ($319.98) |
| 2022 | $925.25 | 47 | Otsuka America Pharmaceutical, Inc. ($311.44) |
| 2021 | $1,007 | 56 | AbbVie Inc. ($274.29) |
| 2020 | $763.86 | 47 | Otsuka America Pharmaceutical, Inc. ($246.47) |
| 2019 | $847.63 | 63 | Otsuka America Pharmaceutical, Inc. ($324.50) |
| 2018 | $897.60 | 55 | Seattle Genetics, Inc. ($183.61) |
| 2017 | $450.64 | 32 | Allergan Inc. ($109.76) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neuropsychiatry | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 08/30/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Travel and Lodging | Cash or cash equivalent | $56.28 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: CNS | ||||||
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Insomnia | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Neuroscience | ||||||
| 07/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: Neuroscience | ||||||
| 06/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 118 | 690 | $117,640 | $44,299 |
| 2022 | 5 | 159 | 801 | $137,800 | $55,606 |
| 2021 | 5 | 158 | 805 | $143,065 | $63,809 |
| 2020 | 6 | 191 | 819 | $146,465 | $56,877 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 212 | $42,400 | $17,295 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 232 | $40,600 | $13,169 | 32.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 133 | $19,950 | $8,283 | 41.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 26 | 113 | $14,690 | $5,553 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 260 | $52,000 | $21,802 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 232 | $40,600 | $14,425 | 35.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 32 | 170 | $22,100 | $8,797 | 39.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 15 | 109 | $16,350 | $6,927 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 30 | $6,750 | $3,655 | 54.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 296 | $59,200 | $26,844 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 205 | $35,875 | $14,280 | 39.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 14 | 129 | $19,350 | $8,996 | 46.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 62 | $13,950 | $7,540 | 54.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 27 | 113 | $14,690 | $6,150 | 41.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 357 | $70,600 | $27,286 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 178 | $30,650 | $9,665 | 31.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 27 | 143 | $18,090 | $7,830 | 43.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 66 | $14,500 | $6,268 | 43.2% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 12 | 55 | $8,200 | $3,816 | 46.5% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 11 | 20 | $4,425 | $2,012 | 45.5% |
About Dr. Nathan Currier, M.D
Dr. Nathan Currier, M.D is a Psychiatry healthcare provider based in Riverton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1407085848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Currier, M.D has received a total of $12,537 in payments from pharmaceutical and medical device companies, with $6,355 received in 2024. These payments were reported across 419 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,126).
As a Medicare-enrolled provider, Currier has provided services to 626 Medicare beneficiaries, totaling 3,115 services with total Medicare billing of $220,591. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Riverton, UT
- Active Since 07/07/2009
- Last Updated 03/27/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407085848
Products in Payments
- Sunosi (Drug) $5,612
- REXULTI (Drug) $1,928
- VRAYLAR (Drug) $828.41
- SPRAVATO (Drug) $471.53
- INGREZZA (Drug) $381.91
- ABILIFY MAINTENA (Drug) $344.87
- CAPLYTA (Drug) $303.12
- TRINTELLIX (Drug) $236.95
- Auvelity (Drug) $218.08
- SUNOSI (Drug) $194.27
- ADCETRIS (Biological) $183.61
- Dayvigo (Drug) $170.63
- HETLIOZ (Drug) $161.28
- Fanapt (Drug) $124.56
- Trintellix (Drug) $115.68
- LYBALVI (Drug) $88.42
- QUVIVIQ (Drug) $86.99
- BRINTELLIX (Drug) $85.15
- ABILIFY MYCITE (Drug) $83.59
- Hetlioz (Drug) $71.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.